The Centers for Disease Control and Prevention recently granted emergency use authorization for the COVID-19 vaccine made by Novavax to be used as a booster. Now its use could expand as a first vaccine.
It is a different type of vaccine than what has been previously approved or authorized in the U.S. Novavax uses a more traditional technology, similar to that used in vaccines for flu, Hepatitis B, and whooping cough.
KPRC 2 News Today spoke with Novavax Executive Vice President & Chief Communications Officer Silvia Taylor about how to decide if this new vaccine offering is right for you and your family.
Watch the interview in the video player above.
FOR MORE INFORMATION VISIT: